by Susan Eustis
The doctors who attended the IBM clinical rounds lecture by IBM at Lahey clinic on February 10 were talking about the prospect of using Watson computing to tackle new drug development. They wanted to know more about what the implications were. Drug development was mentioned as one of the aspects of the presentation at Lahey clinic by Dan Cerutti General Manager, IBM Watson for Healthcare.
Watson is a collection of processors, not greatly different from what are used in a desktop computer, but implemented on a massive scale. Whereas in a desktop computer might have one or two processors, in the typical Watson supercomputer there are thousands of those processors.
At the Lahey Clinic Medical Center, Burlington Medical Grand Rounds this was all the buzz, “What does he mean that Watson can be used to develop new drugs faster?” .
Part of the meaning is that on the Watson computer because there are so many processors, and that they are all interconnected, there is just a lot of pure automated process available to search out different scenarios and develop answers. Because the kzillions of processing modules on Watson can all work together and share information back and forth, there is .more intelligence being applied to a problem. Watson does not get tired, it works 24 hours per day, 365 days a year. The IBM Blue Gene computer can perform 25 trillion computations every second, making it tens of thousands of times faster than a home PC.
John Wagner at the IBM Research Collaboration for Life Sciences group commented recently that “what used to take many days can now be done in several minutes.” Watson can tackle much larger problems than a team of humans can. This holds the opportunity for science to progress in a dramatic manner, faster than has been possible in all of human history before now.
This means that Watson by offering more computing power changes the landscape of science, the problems that are addressed and the scale on which they are thought about lets scientists do new things that could not be done before.
One can imagine that as the system develops the ability to model how drugs interact with their targets and how they affect an organism as a whole, that the scientific process begins to show signs of benefiting from automated process.
The physicians at Lahey were wanting to know what happens when Watson begins to attack drug development problems, they were kind of excited. There was the feeling that the revolution seems to have already begun.
The aim is to drastically reduce that time of discovery. The ability to simulate very powerful simulations, complex simulations and, reduce the time it takes to discover new drugs, this is a major breakthrough. Potentially 80% of the time it now takes to discover a drug could be eliminated with automated process. .